by Oncology Brothers
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at [email protected]
Language
🇺🇲
Publishing Since
11/7/2022
Email Addresses
0 available
Phone Numbers
0 available
April 21, 2025
Drs. Rahul Gosain and Rohit Gosain interview Dr. Devika Das and Dr. Fernando Lopez-Rios about identifying HER2 alterations in lung cancer patients, emphasizing biomarker testing and precision medicine.
April 14, 2025
Dr. Rahul Gosain and Dr. Rohit Gosain interview Dr. Joshua Sabari about the latest lung cancer treatment findings from the European Lung Cancer Conference 2025
April 10, 2025
Dr. Aman Chauhan discusses the FDA approval of cabozantinib for neuroendocrine tumors with Drs. Rohit and Rahul Gosain, highlighting the CABINET study and treatment strategies in this interview.
Sam and Karine
Vinay Prasad, MD MPH
Research To Practice
American Society of Clinical Oncology (ASCO)
Dr Neil Love
The Curbsiders Internal Medicine Podcast
American Society of Clinical Oncology (ASCO)
Freakonomics Radio + Stitcher
NPR
The New York Times
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
OncLive® On Air
New York Times Opinion
NPR
The Uromigos
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.